<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16677">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01960309</url>
  </required_header>
  <id_info>
    <org_study_id>AMI-NCS</org_study_id>
    <nct_id>NCT01960309</nct_id>
  </id_info>
  <brief_title>Minimal Invasive Imaging of Coronary Artery Disease in Patients With Asymptomatic Myocardial Injury After Major Non-cardiac Surgery.</brief_title>
  <acronym>AMI-NCS</acronym>
  <official_title>Minimal Invasive Imaging of Coronary Artery Disease in Patients With Asymptomatic Myocardial Injury After Major Non-cardiac Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <authority>Netherlands:  Independent Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional pilot study to assess coronary artery disease with minimal
      invasive techniques in patients with asymptomatic troponin elevation after noncardiac
      surgery. The primary objective is to quantify coronary artery disease, as determined by
      coronary CT and MR, as a cause of postoperative myocardial injury. The secondary objective
      is to correlate coronary calciumscore to postoperative levels of troponin.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Coronary artery disease</measure>
    <time_frame>Within 1 month after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Coronary artery disease with luminal narrowing &gt; 50 % in one or more major epicardial vessels by CCTA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coronary calcium score</measure>
    <time_frame>Within 1 month after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Agatston coronary calcium score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extent of coronary artery atherosclerosis</measure>
    <time_frame>Within 1 month after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Presence and extent of coronary artery atherosclerosis as measured with coronary CCTA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal myocardial injury</measure>
    <time_frame>Within 1 month after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Minimal myocardial injury measured by late gadolinium enhancement on CMR.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Myocardium; Injury</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1. TnI elevation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TnI 0.06-0.60ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. TnI elevation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TnI 0.61-6.00 ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3. TnI elevation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TnI&gt;6.00 ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4. TnI elevation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TnI &gt;6.00 ng/ml, ischemia on ECG and Hb&lt;5.1. Intervention: minimal invasive cardiac imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5. TnI elevation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TnI &gt;6.00 ng/ml, ischemia on ECG and Hb&gt;5.0. Intervention: minimal invasive cardiac imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TnI &lt;0.06 ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Minimal invasive cardiac imaging</intervention_name>
    <description>Coronary CT angiography (CCTA)
Coronary magnetic resonance imaging (CMR)
Echocardiography</description>
    <arm_group_label>1. TnI elevation</arm_group_label>
    <arm_group_label>2. TnI elevation</arm_group_label>
    <arm_group_label>3. TnI elevation</arm_group_label>
    <arm_group_label>4. TnI elevation</arm_group_label>
    <arm_group_label>5. TnI elevation</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major noncardiac surgery with a planned minimal postoperative hospital stay of 2 days

          -  Age &gt; 59 years

          -  Troponin_I elevation &gt; 0.06 ng/ml in the first 3 post-operative days

          -  No clinical symptoms of myocardial ischemia

        Exclusion Criteria:

          -  Perioperative troponin elevation due to other factors than coronary artery disease
             such as proven pulmonary embolism or sepsis

          -  Perioperative ST-elevation myocardial infarction (STEMI)

          -  Perioperative symptomatic angina with troponin elevation

          -  Patients with a history or ECG-signs of myocardial infarction

          -  Patients with pre-existent heart failure, left ventricular dysfunction, significant
             valvular disease or left ventricle hypertrophy

          -  Patients with significant valvular disease or left ventricle hypertrophy determined
             postoperatively with echocardiography.

          -  Contra-indication for CMR such as claustrophobia or metal prosthesis

          -  Allergic reaction to CT-contrast or gadolinium

          -  Renal dysfunction with GFR &lt; 50 ml/min, as determined after the operation

          -  Unstable hemodynamics or other conditions disabling transport to the Radiology
             department

          -  Expected major discomfort or substantial increase in pain sensation by undergoing
             CCTA or CMR

          -  Admission at the ICU

          -  Poor prognosis due to other medical conditions e.g. malignancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hendrik M. Nathoe, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hendrik M. Nathoe, MD PhD</last_name>
    <phone>+31 88 755 7273</phone>
    <email>H.M.Nathoe@umcutrecht.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrik M. Nathoe, MD PhD</last_name>
      <phone>+ 31 88 755 7273</phone>
      <email>h.m.nathoe@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Hendrik M. Nathoe, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 8, 2013</lastchanged_date>
  <firstreceived_date>July 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>Wilton A van Klei</investigator_full_name>
    <investigator_title>W.A. van Klei, MD PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
